
MK-886 (L 663536) | FLAP 抑制剂 | MCE
MK-886 (L 663536) is a potent, cell-permeable and orally active FLAP (IC50 of 30 nM) and leukotriene biosynthesis (IC50 s of 3 nM and 1.1 μM in intact leukocytes and human whole blood, respectively) inhibitor. MK-886 is also a non-competitive PPARα antagonist and can induce apoptosis [1] [2] [3].
MK-886 - Wikipedia
MK-886, or L-663536, is a leukotriene antagonist. It may perform this by blocking the 5-lipoxygenase activating protein (FLAP), thus inhibiting 5-lipoxygenase (5-LOX), [1] and may help in treating atherosclerosis.
MK-886 (MK-886) - 药物靶点:FLAP x PPARα_专利_临床_研发
MK-886: 一种FLAP抑制剂、PPARα抑制剂药物,由Merck Sharp & Dohme Corp. (Merck Sharp & Dohme Corp.)公司最早进行研发,目前全球最高研发状态为临床前,作用机制: FLAP抑制剂 (5-脂氧合酶激活蛋白抑制剂),PPARα抑制剂 (过氧化物酶体增长因子活化受体α抑制剂),治疗领域: 免疫 ...
MK-886, an inhibitor of the 5-lipoxygenase-activating protein, …
2009年4月17日 · MK-886, an inhibitor of the 5-lipoxygenase-activating protein (FLAP), potently suppresses leukotriene biosynthesis in intact cells and is frequently used to define a role of the 5-lipoxygenase (EC 1.13.11.34) pathway in cellular or animal models of inflammation, allergy, cancer, and cardiovascular disease.
MK-886 (L 663536) | FLAP Inhibitor | MedChemExpress
MK-886 (L 663536) is a potent, cell-permeable and orally active FLAP (IC50 of 30 nM) and leukotriene biosynthesis (IC50 s of 3 nM and 1.1 μM in intact leukocytes and human whole blood, respectively) inhibitor. MK-886 is also a non-competitive PPARα antagonist and can induce apoptosis [1][2][3].
MK 886 | Lipoxygenase Inhibitors: R&D Systems
MK 886 is a potent inhibitor of 5-lipoxygenase-activating protein (FLAP) (IC 50 = 30 nM for inhibition of [125 I]-L-691,678 photoaffinity labelling). Inhibits leukotriene biosynthesis (IC 50 = 3 nM in human polymorphonuclear leukocytes).
MK-886 5-脂氧合酶激活蛋白 (FLAP)抑制剂/PPARα拮抗剂|CAS …
MK-886是一种白三烯生物合成的抑制剂,能够抑制5-脂氧合酶激活蛋白(FLAP)。 此外,MK-886还是PPARα的拮抗剂。 产品性质
MK-886 | COX | FLAP | PPAR | Leukotriene Receptor | TargetMol
MK-886是一种抑制5-脂氧合酶激活蛋白 (FLAP)的化合物,能强效抑制完整细胞内的白三烯生物合成,常用于确定5-脂氧合酶 (EC 1.13.11.34)途径在细胞或动物模型中对炎症、过敏、癌症和心血管疾病的作用。 MK-886对分离的COX-1的抑制作用(IC50=8 µM),可以阻断由COX-1衍生的产物12 (S)-羟基-5-顺-8,10-反-十七碳三烯酸 (12-HHT)和血栓素B2在人类洗涤血小板中对胶原蛋白以及外源性花生四烯酸的响应中的形成(IC50=13–15 µM)。 分离的COX-2受到的影响较 …
- 评论数: 10
MK 886 | Lipoxygenases | Tocris Bioscience
MK 886 is a potent inhibitor of 5-lipoxygenase-activating protein (FLAP) (IC 50 = 30 nM for inhibition of [125 I]-L-691,678 photoaffinity labelling). Inhibits leukotriene biosynthesis (IC 50 = 3 nM in human polymorphonuclear leukocytes).
MK-886 sodium salt (Synonyms: L 663536 sodium salt) - MCE-生 …
MK-886 (L 663536) sodium salt is a potent, cell-permeable and orally active FLAP (IC50 of 30 nM) and leukotriene biosynthesis (IC50 s of 3 nM and 1.1 μM in intact leukocytes and human whole blood, respectively) inhibitor. MK-886 sodium salt is also a non-competitive PPARα antagonist and can induce apoptosis [1] [2] [3].